REYON Pharmaceutical Co., Ltd. (KRX:102460)
South Korea flag South Korea · Delayed Price · Currency is KRW
10,920
-90 (-0.82%)
At close: Apr 16, 2025, 3:30 PM KST

REYON Pharmaceutical Market Cap

REYON Pharmaceutical has a market cap or net worth of 205.42 billion as of April 17, 2025. Its market cap has decreased by -30.22% in one year.

Market Cap
205.42B
Enterprise Value
399.26B
Revenue
148.30B
Ranking
n/a
PE Ratio
49.56
Stock Price
10,920.00

Market Cap Chart

Since June 10, 2010, REYON Pharmaceutical's market cap has increased from 164.55B to 205.42B, an increase of 24.83%. That is a compound annual growth rate of 1.50%.

History

DateMarket Cap% Change
Apr 18, 2025205.42B-12.77%
Dec 30, 2024235.50B-22.37%
Dec 28, 2023303.36B-21.07%
Dec 29, 2022384.35B-39.10%
Dec 30, 2021631.11B61.64%
Dec 30, 2020390.43B47.64%
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 28, 2017 Pro Pro
Dec 29, 2016 Pro Pro
Dec 30, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Samsung Biologics 75.37T
Celltrion 34.28T
ALTEOGEN 20.04T
Yuhan 8,580.84B
SK Biopharmaceuticals 8,144.58B
HLB Co., Ltd. 7,356.32B
LigaChem Biosciences 3,856.78B
Peptron 3,778.83B
Market Cap Rankings